Reynold Syndrome
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. (NCT05168215) | Elpen Pharmaceutical Co. Inc. | 2022-01-01 |
Track Reynold Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.